ASIC approves C3 name change
By Dylan Bushell-Embling
Tuesday, 17 June, 2008
Tuesday, 17 June, 2008
The Australian Securities and Investments Commission (ASIC) has approved the request by Clinical Cell Culture (ASX: CCE) to rename itself Avita Medical.
The name change will take effect on June 26, when Avita will begin trading on the ASX under the code AVH.
Related News
Quitting smoking increases life expectancy even for seniors
Although the benefits of quitting smoking diminish with age, there are still substantial gains...
Stem cell transplants treat blindness in mini pigs
Scientists have successfully transplanted retinas made from stem cells into blind mini pigs,...
Sugary drinks raise cardiovascular disease risk, but occasional sweets don't
Although higher sugar intake raises your risk of certain cardiovascular diseases, consuming sweet...
